Lethal cardiac tachyarrhythmia in a patient with neonatal carnitine-acylcarnitine translocase deficiency

Pediatric and Developmental Pathology

Volumn 4, Issue 6, 2001, Pages 573-579

  Choong, Karen ^a   Clarke, J T R ^a   Cutz, E ^a   Pollit, R J ^b   Olpin, S E ^b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Cardiac arrhythmia; Carnitine; Fatty acid oxidation

Indexed keywords

ACYLCARNITINE CARNITINE TRANSLOCASE; CARNITINE ACYLTRANSFERASE; CARRIER PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CASE REPORT; CONTROLLED STUDY; ENZYME DEFICIENCY; FATTY ACID OXIDATION; FATTY LIVER; HEART MITOCHONDRION; HEART MUSCLE CELL; HISTOPATHOLOGY; HUMAN; KIDNEY; MALE; MITOCHONDRIAL MEMBRANE; NEWBORN; PRIORITY JOURNAL; STEATOSIS; TACHYCARDIA;

CARNITINE O-ACETYLTRANSFERASE; CELLS, CULTURED; FATAL OUTCOME; FATTY ACIDS; FIBROBLASTS; HUMANS; INFANT, NEWBORN; KIDNEY; LIPIDOSES; LIVER; MALE; MICROSCOPY, ELECTRON; MITOCHONDRIA; MYOCARDIUM; ORGANELLES; OXIDATION-REDUCTION; TACHYCARDIA, VENTRICULAR;

EID: 0035166379     PISSN: 10935266     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10024001-0101-7     Document Type: Article

References (19)

1. Carnitine-acylcarnitine translocase deficiency
2. Carnitine-acylcarnitine translocase deficiency with severe hypoglycemia and auriculoventricular block
3. Carnitine acylcarnitine translocase deficiency: Implications in human pathology
4. Mitochondrial carnitine-acylcarnitine translocase deficiency presenting as sudden neonatal death
5. A patient with carnitine-acylcarnitine translocase deficiency with a mild phenotype
6. Carnitine acylcarnitine translocase deficiency - A mild phenotype
7. Infantile form of carnitine palmitoyltransferase deficiency with hepatomuscular symptoms and sudden death
8. Inherited cardiomyopathies
9. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children
10. Efficiency of metabolic screening in childhood cardiomyopathies
11. Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation
12. Lethal neonatal multiorgan deficiency of carnitine palmitoyltransferase II
13. Lethal neonatal deficiency of carnitine palmitoyltransferase II associated with dysgenesis of the brain and kidneys
14. Amiodaron-induced lymphocyte toxicity and mitochondrial function
15. Evaluation of human blood lymphocytes as a model to study the effects of drugs on human mitochondria. Effects of low concentrations of amiodarone on fatty acid oxidation
16. Effect of amiodarone on the expression of myosin isoforms and cellular growth of cardiac muscle cells in culture
17. Acute effects of amiodarone on ultrastructure and electrical activity of isolated guinea pig hearts
18. Inhibition of carnitine palmitoyltransferase-I in the rat heart and liver by perhexiline and amiodarone
19. Direct evidence that perhexiline modifies myocardial substrate utilisation from fatty acids to lactate